Vermont, Oregon Enact 340B Contract Pharmacy Access Laws; Vermont Measure Includes Controversial Hospital Price Caps

Vermont Gov. Phil Scott (R) and Oregon Gov. Tina Kotek (D) each signed 340B legislation in their states on June 11.
Vermont and Oregon yesterday became the latest states to enact 340B contract pharmacy access laws, with Vermont’s new statute also [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Appellate Court Fast-Tracks Drugmakers’ Appeal of 340B Rebate Ruling

A federal appellate court in Washington, D.C. will hear two drugmakers' appeal of a lower courts 340B rebate ruling on an expedited schedule.
A federal appellate court in Washington, D.C. is fast-tracking Novartis and Bristol Myers Squibb’s (BMS) appeal of a lower court [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

CMS Offers New Details on Medicare Drug Price Negotiations, 340B Advocates Raise Concerns About Impact on Program

340B stakeholders raised concerns about May 12 draft guidance on the IRA Medicare Drug Price Negotiation Program's “manufacturer effectuation of the maximum fair price in 2026, 2027 and 2028,” among other things.
The Centers for Medicare and Medicaid Services (CMS) released new details this week to help stakeholders navigate the Inflation Reduction [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

J&J, Lilly and GSK to Refund 340B Covered Entities for Overcharges

Johnson & Johnson and two other major drugmakers recently announced refunds for 340B covered entities that purchased certain drugs in 2022 and 2023.
Three major drugmakers recently announced refunds for 340B covered entities that purchased certain drugs in 2022 and 2023 following recalculations [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

How Oklahoma Lawmakers Defied Their Governor and Fought Dark Money to Enact a 340B Contract Pharmacy Access Law

Oklahoma state lawmakers overrode their governor's veto to enact a 340B contract pharmacy access law despite strong opposition from dark money groups and conservative influencers.
In the final hour of Oklahoma’s 2025 legislative session, as the clock neared 11 p.m. on May 29, state legislators [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Third Straight HRSA Audit Finds Drugmaker 340B Overcharges in 2025

HRSA released its latest drugmaker audit findings, which resulted in sanctions against India-based Aurobindo Pharma.
For the third straight time in 2025, a federal audit has found a drug manufacturer overcharged covered entities for 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug-Industry Funded Study Finds Utilization Drives 340B Program Growth, Not Rising Drug Prices

A recent drug-industry funded study in Health Affairs Scholar found that increased utilization, rather than rising drug prices, drives 340B program growth.
A recent drug-industry-funded study attributes the 340B program’s recent growth to increased utilization—not rising drug prices. The May 21 study, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In Emergency Motion, Novartis and BMS Urge Appellate Court to Fast-Track Their Appeals of 340B Rebate Ruling

Novartis and BMS filed an emergency motion with the federal appeals court in Washington, D.C. to appeal a recent ruling on drugmaker 340B rebates.
Novartis and Bristol Myers Squibb (BMS) are asking a federal appeals court to expedite their challenge to a recent ruling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Amgen Exempts Tennessee Providers From 340B Contract Pharmacy Restrictions Despite New Law’s Carve Out

Amgen announced it will exempt Tennessee from its contract pharmacy restrictions, surprising some providers in the state due a grandfather clause in Tennessee's law.
Pharmaceutical giant Amgen recently announced it will exempt Tennessee providers from its contract pharmacy restrictions despite a carve out in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

SpecGx to Offer Covered Entities Refunds for a Record 30-Plus Years of 340B Overcharges

Mallinckrodt's subsidiary, SpecGx, will offer refunds to covered entities for over 30 years of overcharges.
SpecGx, a generic subsidiary of Mallinckrodt Pharmaceuticals, will refund 340B covered entities that purchased addiction treatment medication Methadose for above [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live